DiscGenics

DiscGenics

DiscGenics

Regenerative Cell Therapy for Chronic Back Pain.
Type
B2c
Founded
2007
Raised
$64M
Follow us
Alexa global traffic share
27 Aug 2020
$50,000,000
Venture capital (Series C)
Ci:z Investment LLP, Eagle Fund SP1 LLP, Medical Incubator Japan (MIJ), +1

DiscGenics Raises $50M in Series C Funding

FinSMEs
26 Sep 2017
$14,000,000
Venture capital (Series B)